Table of Contents
Pharmacy Compounding Advisory Committee July 13, 2000
Transdermal Drug Delivery System (TDS)
TDS
Types of TDS
PPT Slide
Factors Considered: Products are demonstrably difficult to compound
Drug Delivery System
Drug Formulation and Consistency
Drug Formulation and Consistency
Drug Formulation and Consistency
Transdermal Drug Delivery System Biopharmaceutics Considerations
Bioavailability
Testing and Quality Assurance
Preliminary Findings Difficulties in compounding result from the following characteristics and requirements:
Preliminary Conclusion
|
Author: CDER User
|